Signs of Percocet Use Disorder
Percocet use disorder is a medical condition, not a character failing, and it often looks less dramatic than people expect. The DSM-5 defines opioid use disorder by a cluster of behaviors and physiological changes — two or more of eleven criteria in a twelve-month period. For Percocet specifically, the picture usually combines classic opioid-dependence signs with some that are specific to the combination-pill pathway:
- Tolerance and dose escalation. The 5/325 tablets that worked for the first week aren’t enough by month two. Two tablets becomes three becomes four. The daily total quietly drifts above what was originally prescribed — even though no one decision to take more was ever especially dramatic.
- Running out early. The 30-day bottle lasts 24 days. Then 19. Then 14. Lost-prescription, stolen-bottle, or “flushed them by mistake” stories start becoming more frequent. This is one of the most reliable patterns clinicians see.
- Asking multiple providers for refills. An ER visit here, an urgent-care visit there, a call back to the original prescribing surgeon, a prescription from a dentist for unrelated tooth pain. Tennessee’s CSMD (Controlled Substance Monitoring Database) now flags this pattern in real time, which tends to push patients toward the next sign on this list.
- Using someone else’s prescription. A family member’s leftover surgical pills. A friend’s script. The Percocet from last year’s dental procedure that was supposed to have been thrown out. Roughly half of people who misuse prescription opioids obtained them from a friend or relative.
- Using for anxiety, mood, or sleep rather than pain. The original pain event may be long over, but the pills have become load-bearing for something else — quieting an anxious evening, getting through a hard work week, falling asleep. This shift from pain management to emotional management is a common pivot point in prescription-opioid use disorder.
- Withdrawal symptoms between doses. Muscle aches, yawning, sweating, runny nose, anxiety, and GI upset showing up 8–12 hours after the last dose. Many Percocet patients describe “needing the morning dose to feel normal” long before they would call what they’re experiencing “withdrawal.”
- Transitioning to stronger or cheaper alternatives. When prescription access closes — typically when a prescriber declines a refill or the CSMD flag goes up — the next step is often illicit pills (“30s,” counterfeit pressings), heroin, or fentanyl-contaminated product. The same patient who never imagined buying drugs on the street can end up there because the alternative is withdrawal.
- Hiding use. Taking pills in private. Switching where bottles are stored. Minimizing or lying about how many are left. Family members often notice this before they notice the quantity involved — the behavior around the medication, more than the medication itself.
- Liver-related signs in long-term high-dose users. Persistent fatigue, right-upper-quadrant abdominal discomfort, nausea, easy bruising, or yellowing of the skin or eyes (jaundice) can reflect acetaminophen-related liver strain. These tend to be late-stage signs and don’t appear in the majority of our patients, but they’re worth naming specifically because they’re one of the things that differentiates long-term Percocet use from other opioids and because they’re the reason we run LFTs at intake.
- Continued use despite consequences. Use that persists through financial strain, job instability, damaged relationships, or medical concerns is one of the DSM-5 criteria and one of the clearest signals that pills have moved past being a pain management tool.
You don’t have to hit every item on this list. You don’t need to have lost a job, a relationship, or a custody arrangement. The DSM-5 threshold for opioid use disorder is 2 of 11 criteria in a 12-month period. Mild, moderate, and severe are all treatable — and earlier is almost always easier than later.
Percocet Withdrawal: Timeline and Symptoms
Because Percocet’s opioid component is oxycodone, Percocet withdrawal is clinically oxycodone withdrawal. The acetaminophen half doesn’t produce dependence or withdrawal — it’s a non-opioid analgesic that wouldn’t have made the pills hard to stop on its own. It’s the oxycodone that your nervous system built tolerance and dependence around, and it’s the oxycodone that the withdrawal picture reflects.
For most healthy adults, opioid withdrawal is not directly life-threatening the way alcohol or benzodiazepine withdrawal can be. It is, however, severe enough to drive most unmedicated quit attempts to fail. That’s not weakness — that’s physiology, and medication-assisted treatment is designed specifically to prevent the withdrawal phase rather than force you through it.
One clinical caveat is worth naming up front. A chronic, high-dose extended-release oxycodone patient and a patient dependent on six Percocet 5/325 a day are both in opioid withdrawal if they stop abruptly, but the severity varies meaningfully. Percocet patients tend to have a lower total daily opioid load than long-term chronic-pain patients or long-term OxyContin users, which usually means a milder acute course. The pattern, however, is the same.
A general timeline for Percocet withdrawal looks like this:
- First 8 to 12 hours after last dose. Early symptoms: anxiety, restlessness, irritability, muscle aches, yawning, watery eyes, runny nose, mild sweating, and cravings. Sleep is usually disrupted the first night. This is about the same onset window as other short-acting full-agonist opioids; it’s faster than fentanyl (8–24+ hours) and slower than very short-acting opioids.
- Day 1 to day 3 (peak). Full symptom picture: nausea, vomiting, diarrhea, abdominal cramping, alternating chills and sweating, dilated pupils, goosebumps, deep muscle and bone aches, profound fatigue, and intense cravings. Heart rate and blood pressure rise. Insomnia persists or worsens. This is the window in which most unmedicated quit attempts fail.
- Day 3 to day 7. Acute GI symptoms gradually subside. Appetite may start to return. Sleep remains fragmented. Cravings remain strong. Mood and anxiety often worsen here as the body re-regulates.
- Week 2 and beyond (post-acute withdrawal). Low energy, difficulty concentrating, mood changes, anhedonia, and intermittent cravings can last weeks to several months unmedicated. This is not a sign treatment isn’t working — it’s the nervous system slowly recalibrating after months or years of consistent opioid exposure. MAT dramatically shortens and softens this phase.
Two clinical considerations matter specifically for Percocet patients:
- Induction timing. Starting buprenorphine (Suboxone, Sublocade, Brixadi) too soon after your last Percocet dose can trigger precipitated withdrawal — a sudden, severe worsening of symptoms. For Percocet, the target induction window is typically when the COWS (Clinical Opiate Withdrawal Scale) score reaches a moderate level, usually 8–24 hours after the last dose. Your provider measures COWS at intake to time induction correctly. If you’ve been exposed to counterfeit pills (which are commonly pressed with fentanyl), the window is often longer — 36–72 hours — because fentanyl clears more slowly than oxycodone.
- Acetaminophen exposure stops at induction. The moment you switch from Percocet to buprenorphine-based MAT, your daily acetaminophen dose drops to zero from whatever it had been. For patients who’ve been running chronically high APAP loads, that single change begins the liver’s recovery process. We’ll also run baseline LFTs at intake so we know what we’re starting from.
How We Treat Percocet Addiction
At Restoration Recovery, Percocet use disorder is treated with a combination of medication, behavioral support, and — when warranted — liver-function monitoring given the APAP component of the exposure history. Every opioid patient we see is evaluated for medication-assisted treatment because the evidence supporting it is overwhelming — more than a 50% reduction in fatal overdose risk, significantly longer retention in treatment, and sharply lower rates of illicit opioid use.
The medication options available to you are:
- Suboxone (daily film or tablet). A combination of buprenorphine and naloxone taken sublingually — available as a dissolving film or tablet placed under the tongue. Buprenorphine is a partial opioid agonist: it stabilizes cravings and prevents withdrawal at the same opioid receptors oxycodone was acting on, but with a ceiling effect on euphoria and respiratory depression. For many Percocet-first patients, same-day Suboxone induction is clinically appropriate and dramatically easier than a cold-turkey attempt. The naloxone is inactive when the medication is taken correctly; it’s included to discourage misuse by injection.
- Sublocade (monthly injection). A long-acting extended-release form of buprenorphine administered once per month at our clinics. Many patients who have started with Suboxone eventually transition to Sublocade because it removes the daily decision-making around taking medication, holds steadier blood levels throughout the month, and — importantly for patients whose dependence began with pill-taking — removes the pill ritual entirely. Per FDA labeling, Sublocade requires at least 7 days of transmucosal buprenorphine (Suboxone) before the first injection.
- Brixadi (weekly, bi-weekly, or monthly injection). Another extended-release buprenorphine injection, with flexible dosing intervals. Brixadi’s weekly or bi-weekly options can help patients still finding the right maintenance dose, or who want a shorter interval than Sublocade’s monthly cadence. Like Sublocade, Brixadi is ordered per-patient and administered at a follow-up visit once the medication arrives.
Medication alone is effective. Medication paired with behavioral and medical support is more effective. We pair MAT with:
- Individual counseling with licensed therapists experienced in substance use disorder. For Percocet patients, counseling tends to surface material specific to the prescription-opioid pathway — the original pain event, the relationship with the original prescribing provider, the shame of needing pills to function, and what the combination pill represented before it became a problem.
- Certified peer support from specialists with lived experience. Several of our peers started on the same prescription-to-street arc many of our Percocet patients are walking. That conversation can land differently than a strictly clinical one.
- Intensive outpatient programming (IOP) for patients who benefit from a more structured treatment schedule — delivered in a group format by design. IOP is the only group-setting service we offer, and it’s a separate structured program rather than an informal group activity.
- Liver-function monitoring when clinically indicated. For Percocet patients with long daily histories, we run baseline LFTs (ALT, AST, ALP, bilirubin) at intake. In most cases, results are normal or mildly elevated and improve after MAT starts and daily acetaminophen exposure stops. When results warrant closer follow-up, we coordinate with primary care or hepatology.
- Integrated care for co-occurring conditions, including anxiety, depression, trauma, chronic pain, and hepatitis C. For prescription-opioid patients, chronic pain and anxiety are particularly common and directly relevant to how long people stay in treatment; we address them, not hand them off.
Restoration Recovery is an outpatient clinic. We do not provide medical detox or residential care. For most patients with Percocet use disorder, a formal inpatient detox is not required — medication-assisted treatment can begin at the appropriate COWS-score window after last use, under clinical supervision. For patients who need a higher level of care before starting outpatient MAT, we coordinate with regional referral partners.
What to Expect at Your First Appointment
Your first visit typically lasts 60 to 120 minutes and follows a four-step clinical flow:
- Intake. You’ll complete paperwork and a clinical intake. For opioid use disorder, this includes a DSM-5 assessment to confirm the diagnosis and its severity (mild, moderate, or severe based on how many of the 11 criteria you meet in a 12-month period), and a COWS (Clinical Opiate Withdrawal Scale) score to measure your current withdrawal state. The COWS score guides whether you’re clinically ready to begin buprenorphine the same day without risking precipitated withdrawal. For Percocet patients with a long daily use history, a baseline liver function panel (LFTs) is also part of the standard intake workup given the chronic acetaminophen exposure.
- Counseling. You’ll meet with a counselor to discuss your substance use history — including the original prescription pathway if that’s how your use started — any previous treatment, any co-occurring mental health conditions, and your personal recovery goals. Any active pain management relationship or concern gets documented here.
- Doctor evaluation. A medical provider reviews your intake, COWS score, counselor notes, and lab findings if available. They walk you through the medication options (Suboxone, Sublocade, Brixadi), explain onset, side effects, and timing, and answer your questions. For patients with long Percocet histories, this is also where any liver-function result or acetaminophen-related concern gets addressed specifically.
- Prescription (and injection ordering, if chosen). If clinically appropriate, you leave the same day with a Suboxone prescription. If you prefer the extended-release route, your provider will order Sublocade or Brixadi during this visit — we don’t stock injections on-site — and you’ll continue on Suboxone as a bridge. Your injection appointment is scheduled for a follow-up once the medication arrives, typically after a short stabilization period on Suboxone (Sublocade’s FDA label requires at least 7 days of transmucosal buprenorphine before the first injection).
Bring a valid photo ID, your insurance card if applicable, and a list of any medications you currently take (including the Percocet strength and daily dose, the original prescribing reason, any OTC acetaminophen-containing products like Tylenol or Nyquil, and any pain medications or benzodiazepines). If you’d like to see the full process walked through step by step before your visit, our guide on what to expect at your first Suboxone appointment covers it in more detail.
Why Medication-Assisted Treatment Works for Percocet
For many patients, the fear of withdrawal is what keeps them stuck. MAT removes that barrier — the medication prevents withdrawal rather than forcing patients to endure it — which is why it works when willpower alone doesn’t.
Medication-assisted treatment is endorsed as the standard of care for opioid use disorder, including prescription opioid use disorder specifically, by the Substance Abuse and Mental Health Services Administration (SAMHSA), the National Institute on Drug Abuse (NIDA), the American Society of Addiction Medicine (ASAM), and the World Health Organization. Prescription opioid use disorder was actually the population in which buprenorphine was most extensively studied before the illicit-fentanyl era — the original large trials (COMBINE, POATS, and others) recruited patients whose dependence began with prescription pills, not injection use. For this population, the evidence base is especially deep.
Large-scale evidence shows that patients with opioid use disorder who receive buprenorphine-based MAT:
- Experience more than a 50 percent reduction in the risk of fatal opioid overdose
- Stay in treatment significantly longer than those receiving counseling alone
- Report fewer cravings and lower rates of illicit opioid use
- Are more likely to maintain employment and stable housing during recovery
- Have lower rates of infectious disease transmission associated with injection use
There’s a second medical benefit specific to Percocet patients that’s worth naming plainly: MAT removes the daily acetaminophen exposure entirely. Buprenorphine contains no APAP. Neither does Suboxone, Sublocade, or Brixadi. For a patient who has been taking 8–12 combination pills a day for months or years, switching to buprenorphine means their daily acetaminophen dose drops from 2,600–3,900 mg to zero, and their liver — which has been quietly metabolizing that exposure the whole time — gets a break in addition to the opioid dependence being addressed. For most patients, mildly elevated baseline LFTs trend back toward normal over the weeks that follow. It’s one of the quiet clinical wins of the transition that patients don’t always expect.
MAT is not a replacement of one drug with another. Buprenorphine’s partial-agonist pharmacology gives it a ceiling effect on euphoria and respiratory depression that full agonists like oxycodone, hydrocodone, and fentanyl don’t have. Blood levels stabilize, the daily cycle of peak-and-crash disappears, the pill-a-day ritual ends, the ongoing APAP exposure ends, and the neurological noise that drove continued use recedes. Patients can engage in counseling, rebuild relationships, and return to work without the daily math of craving, dosing, running out, and withdrawing.
Chronic Pain Considerations
A meaningful share of our Percocet patients arrive with a real chronic pain history — low back pain, post-surgical pain that didn’t fully resolve, a joint injury that kept flaring. Many have been told at some point that starting MAT means giving up pain management. That isn’t how the clinical picture actually works. Buprenorphine is itself a potent analgesic. As a partial opioid agonist, it provides real, measurable pain relief, and plenty of our patients report their pain is better controlled on buprenorphine than it was on escalating Percocet doses — largely because their nervous system is no longer cycling through mini-withdrawal every 4–6 hours between doses. When a patient has an active pain management relationship with another provider, we coordinate rather than compete. The goal is one consistent plan between us, the pain provider, and the patient, not two parallel medication lists that contradict each other.
Why Restoration Recovery
Choosing where to start treatment matters. Restoration Recovery brings together the clinical depth, the practical access, and the kind of care that keeps patients in treatment long enough to get well.
- Chattanooga’s longest-running outpatient addiction treatment clinic. Our providers have decades of clinical experience treating opioid and substance use disorders in Southeast Tennessee — including through the full arc of the prescription-opioid era, the FDA 2011 APAP mandate, the heroin transition, and now the fentanyl contamination of the pill supply. We’ve seen every version of this.
- CARF accredited. The Commission on Accreditation of Rehabilitation Facilities is the gold standard for outpatient addiction care — our accreditation is reviewed on an ongoing basis, not a one-time stamp.
- Four clinic locations across Southeast Tennessee and North Georgia, with telehealth follow-up available for established patients.
- Most major insurance accepted — TennCare, Georgia Medicaid, commercial plans, Medicare, and supplemental Medicare. Our patient services team verifies your benefits before your first visit so there are no surprises.
- Same-day Suboxone appointments in most cases. You don’t have to wait weeks to start.
- One integrated team. Medical providers, counselors, certified peer support specialists, and psychiatric care under one roof — not parallel referral tracks that leave you coordinating your own care. For patients with co-occurring chronic pain, anxiety, depression, or hepatitis C, this matters.
- Licensed in both states. Licensed in Tennessee and Georgia, HIPAA compliant, 42 CFR Part 2 compliant — your treatment is confidential from the first phone call.
Insurance and Access
Restoration Recovery accepts most major insurance plans, including TennCare, Georgia Medicaid, a broad range of commercial plans, and Medicare (plus supplemental Medicare plans). Our patient services team can verify your benefits before your first appointment so you know exactly what to expect in terms of cost.
If you do not have insurance, contact us anyway. We can help you explore options and will walk you through self-pay pricing. For a full list of accepted carriers and details on the verification process, visit our insurance page.
Four Clinic Locations
We operate four outpatient clinics across Southeast Tennessee and North Georgia. All locations offer Percocet addiction treatment with same-day appointments in most cases:
- Chattanooga, TN — 6141 Shallowford Rd, Suite 100, Chattanooga, TN 37421
- Cleveland, TN — Serving Bradley County and surrounding areas
- Soddy-Daisy, TN — Serving Hamilton County north and the Sequatchie Valley
- Ringgold, GA — Serving Catoosa County and Northwest Georgia
Telehealth follow-up visits are available for established patients who have completed their initial in-person evaluation. For directions, hours, and contact information, visit our locations page.
Frequently Asked Questions
I only take Percocet for pain — could I still have use disorder?
Yes, and this is one of the most common clinical pictures we see. Opioid use disorder isn’t defined by why you started taking the pills — it’s defined by whether your current relationship with them meets DSM-5 criteria: tolerance, withdrawal, unsuccessful efforts to cut down, running out early, using more than intended, and continued use despite consequences. A legitimate original prescription is how most of our Percocet patients got here. It doesn’t change the diagnosis, and it doesn’t change what treatment looks like. The pathway in doesn’t determine the pathway out.
Does long-term Percocet hurt my liver?
It can. Every Percocet tablet contains 325 mg of acetaminophen (since the FDA’s 2011 mandate), and chronic high-dose use adds up quickly. The FDA-recommended maximum daily dose of acetaminophen is 4,000 mg, and people dependent on Percocet often exceed that without realizing it — especially if they’re also using OTC acetaminophen-containing products like Tylenol, Nyquil, or Excedrin. Acetaminophen is the single most common cause of acute liver failure in the United States, implicated in nearly half of all cases in the NIDDK-supported Acute Liver Failure Study Group registry. That doesn’t mean you’ve damaged your liver — most of our patients haven’t, and most come back with normal or only mildly elevated labs. It does mean checking LFTs at intake is worth doing so we know your starting point.
What if I’ve already damaged my liver from Percocet use?
The liver is unusually good at recovering once the ongoing injury stops. In most cases, discontinuing daily acetaminophen exposure — which happens automatically when you transition from Percocet to buprenorphine-based MAT — lets the liver heal on its own over weeks to months. If intake labs flag something that needs closer workup, we coordinate with your primary care provider or a hepatologist, and we can also treat co-occurring hepatitis C if that’s part of the picture. The point isn’t to alarm you — it’s to understand the starting point and plan accordingly. The most powerful intervention for an acetaminophen-stressed liver is stopping the ongoing exposure. Starting MAT does exactly that.
What about fake Percocet pressed with fentanyl?
If you’ve been buying pills outside of a pharmacy that look like Percocet — scored “Percocet 10,” oval white or yellow tablets marked with manufacturer numbers — you should assume fentanyl exposure. Counterfeit pressings flooded the illicit pill supply starting around 2016 and are now the dominant illicit pill product nationally. In 2023, U.S. law enforcement seized roughly 115 million counterfeit pills, accounting for about half of all fentanyl seizures that year, and approximately 6 in 10 contained a potentially lethal dose (2 mg or more of fentanyl). The treatment path is the same as for genuine Percocet dependence, but the induction timing is different: because fentanyl clears slowly, the buprenorphine induction window is typically 36–72 hours after last use instead of 8–24. Your COWS score at intake tells your provider exactly where you are.
Is my dental pain prescription why this happened?
A short dental opioid prescription is one of the single most common first exposures we see, and the research backs that up. A University of Michigan analysis of wisdom-tooth patients 13–30 years old found that those who filled their post-extraction opioid prescription were nearly three times as likely to still be filling opioid prescriptions weeks or months later than peers who didn’t fill the script. A separate JAMA Network Open analysis of 56,686 wisdom-tooth patients put the persistent-use rate at 1.3% in the filled-prescription group versus 0.5% in the didn’t-fill group. It’s not that dental pain caused your dependence — it’s that a short acute pain course is sometimes the first contact with a medication your nervous system was going to respond strongly to. That’s neither unusual nor your fault. It is, however, treatable.
Should I get my liver checked before I start MAT?
We handle that at intake. For patients with a long daily Percocet history, a baseline liver function panel (ALT, AST, ALP, bilirubin) is part of the standard intake workup so we know the starting point. You don’t need to arrange it beforehand. If results come back flagged, we coordinate with your primary care provider or a hepatologist; if results are normal, we document the baseline and move forward. Either way, starting buprenorphine-based MAT stops the ongoing acetaminophen exposure, which is the single most important liver-protective step most patients in this situation can take. Don’t let a liver concern delay the call. The right order of operations is: call us, start treatment, run labs at intake, plan from there.
Take the Next Step
Percocet addiction is survivable, and treatment works — whether your use started with a post-surgical prescription, a dental extraction, a back injury that never quite healed, or somewhere messier than that. You don’t have to figure this out alone, you don’t need to have all the answers before you call, and you don’t need to be clean before your first appointment. Our team will walk you through the process from your first phone call to your first visit and every follow-up after that.
Same-day appointments are available in most cases. Contact us today to schedule your evaluation, or call 423-498-2000 to speak with our team directly.
